Genetic variants of SARS-CoV-2 have emerged and are circulating the world throughout the COVID-19 pandemic, such as the U.K. variant B.1.1.7, Brazil variant P.1, and South Africa variant B.1.351. The most recent Indian variant B.1.617 is particularly concerning because of its high prevalence. |
Creative Diagnostics is going full steam ahead on developing a collection of recombinant antigens for these variants, including Spike proteins and Nucleocapsid proteins, covering critical mutations such as K417N/T, L452R, E484K/Q, N501Y and D614G on the Spike protein and R203G, G204R and P13L on the Nucleocapsid protein. We offer reagents that can be used to evaluate the efficacy of the antibodies and vaccinations. |